We evaluated the performance of the Radiometer TCM-1 Transcutaneous Oxygen Monitor in a Class Ill neonatalintensive-care unit during an 1 1-month clinical trial (in excess of 4000 h) in which we monitored 115 infants ranging in gestational age from 24 to 43 weeks and in birthweight from 595 to 4220 g. In vitro transcutaneous partial pressure of oxygen (Ptco2) measurements were accurate within 1 % of the theoretical value and precise (1.4% CV at 156 mmHg) at 44 #{176}C. Determinations at other temperatures were less accurate except in rare instances when specific patient-associated Ptco2/Pao2 bias was identified. In vitro comparison of p)2 (y) and arterial partial pressure of oxygen (Pao2) (x) measurements agreed well (y = 0.90x + 6.9, r = 0.94) except when infants were less than 24 h old. In this latter group the /p2 ratio usually exceeded 1.0 and fluctuated unpredictably. measurements on infants less than 24 h old had to be interpreted cautiously. In general, the PtcO2 and Pa02 measurements agreed sufficiently well for the physicians to use them as the basis for directing patient care.
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prematurity
The use of transcutaneous oxygen (p2) measurements in the care of newborns has been the subject of more than 100 reports. Most of them address experiences with prototype equipment or with special patient-management applications. Interpretation and comparison of these reports is somewhat obscured by inter-instrument design differences, which include the number (1, 2) and size (3) of cathodes, the size and configuration of the heating element (1, 3, 4) , and differences in membrane materials (1) (2) (3) . Moreover, the test protocols described in the literature also vary with respect to the operating temperature (3, (5) (6) (7) (8) , the contact fluid (5, 9, 10) , or electrode preparation (2, 9) .
For these reasons we undertook to evaluate a commercially available instrument with regard to its analytical performance, the factors that influence the quality of the analysis, optimal operating conditions, and the agreement between po2 and determinations of the partial pressure of oxygen in arterial blood (Pa02). 
Division of Clinical

Methods and Materials
Subjects
The subjects The calibration unit was a two-chamber fluid tonometer with variable temperature control. The recorder was set up so that PtcO2 was continuously displayed on the lower half of the chart and the heater power output on the upper. Because the latter is an indicator of blood-flow changes (1), a modification was needed to make the heater power channel as sensitive as possible.
The TCM-1 recorder output signal for the heat channel was 0 to -500 mV, which represented 0 to 500 mW heater power output. The pi2 recorder output signal was 0 to -500 mV, which represented 0 to 200 mmHg.3 Because the signals from the TCM-1 recorder output were negative-going, the zero-volt lead was placed on the positive terminals of the recorder and the PtcOl and heat-signal leads were placed on the negative terminals.
We used a 100-mW span for the heat channel (Y-2 in Figure 1 ) on the upper half of the chart paper, to increase the sensitivity.
In order to do this, the signal was divided by resistors RI and R2, as shown in Figure 1 . The divider put the signal in the proper range so that, with the attenuator for Y-2 set at 1 V full scale, the left half of the chart was adjustable to a 100-mW span. However, for further increased sensitivity, the 100-mW span needed to be adjustable to anywhere in the TCM-l's range of 0-500 mW (e.g., 200-300 mW). Thus, the zero control or the heat channel (Y-2) had to be modified. One end of the zero control potentiometer was connected to -5 V, the other to circuit common. The wire from the post to common was disconnected and moved from circuit common to an 8-V supply on the circuit board, to get the zero-offset capabilities needed. (This was done by unsoldering the purple wire which goes from the Y-2 zero pot to the circuit board and soldering it to the +8 V end of R-39.) The entire system was easily transported on a laboratory cart specially equipped with hospital-grade electrical receptacles and a single 3-rn power cord; it required a minimum of space and only one electrical outlet in the Intensive Care Unit.
We used a National water after a 25-mm equilibrium period and were monitored for I mm after the readings stabilized. They were accurate to within 1% when tested at 0, 52, 145, 250, and 306 mmHg. The gas/liquid ratios were calculated after the p02 of the hydrated gas had been measured in the tonometer chamber above the fluid phase. The gas/liquid ratios observed were 1.00 (49 mmHg/49 mmHg) and 1.01 (240 mmHg/238 mmHg).
We estimated precision from 20 measurements of the Po2 of air with an electrode screwed into an attachment ring on which a silastic membrane had been fixed. The electrode temperature was 44 #{176}C, the mean 02 tension 156 mmHg, and the CV 1.4%.
The thermistor accuracy of the electrode was evaluated at 44 #{176}C by using a thermostated water bath and an NBS-referenced thermometer.
All six electrodes agreed within 0.2 #{176}C, as the manufacturer specifies.
Initial clinical observations.
A pilot study was undertaken to define the parameters for routine transcutaneous 02 tension measurements.
First, we assessed the influence of the electrode temperature on the PtcO2 results. We studied three aspects of electrode response.
The response time to changes in Ptco2i.e., the elapsed time between blood-flow occlusion effected by a cuff, and the response of the recorder pen-varied from 10 to 15s. The equilibrium time-i.e., interval from sensor application to maximum consistent correlation between Pa02 and ptco2-varied from 0.5 to 10 mm, but in most instances it was 1 to 2 mm. Because All patients included in this study were younger than 24 h. n = 60, y = 0.99x + 9. and Pa02 values in individual subjects separately, the relationship was notably different (Figure 2 ). For patient A (plot A), 23 separate comparisons (i.e., separate applications of the electrode) during 30 days were in better agreement (y = 0.99x + 1.47, r = 0.98) than was true of the total population study. Most of the patients exhibit this relationship.
Plot B of Figure 2 illustrates a less-consistent relationship between Ptc02 and Pa02 determinations, which has characteristically more variance. However, no statistically significant difference was evident (t = 0.19, p > 0.05). In this instance the scatter could not be related to deteriorated instrument performance or specimen quality, because all of the above items were carefully controlled.
The patients whose data are illustrated as plots C and D gave bias correlations between the two methods. The Po2 values were consistently higher or lower than the Pa02 values among 15 patients, of whom eight resembled patient C and seven patient D (with more than five data pairs).
In this study, 32 infants younger than 24 h were observed to be a distinct population. the initial PtcO2/paO2 ratio, the rate of change in this ratio, and the final PtcO2/P802 ratio were variable and unpredictable. In our clinical setting, more than 90% of Po2 determinations have been used to monitor changes in oxygenation that result from changes in inspired 02 concentrations.
Other uses include optimization of respirator settings and monitoring the effects of bag ventilization and suctioning. The average measurement time is currently 2.5 h per application. This reflects a monitoring limit of 3 h per application site, imposed to minimize electrode drift and the risk of burns. In this series one second-degree burn was observed, which healed without sequelae.
Arterial blood-gas determinations were used throughout the management period as a control mechanism. Currently, an arterial blood-gas specimen is analyzed every 5.4 h of Ptcos monitoring.
A monthly examination of this statistic shows a threefold fluctuation associated with laboratory and medical staff education and experience.
Discussion
In evaluating the Radiometer transcutaneous 02 monitoring system, we observed that the in vitro accuracy, within 1% of the theoretical value, was equal to that reported for PtcO2 measurements with other systems (2) . It is equal to or better than conventional blood-gas analyzers (13, 14) . Precision studies described here include electrode application. Lofgren (10) also evaluated precision and identified the application process as a source of variability.
He found a CV of 4.3%. The precision observed here (CV 1.4% at 156 mmHg), which includes the electrode-application process, is comparable to the 1.0-3.0% CV achievable at 150 mmHg with conventional blood-gas analyzers (13, 14) . 
